HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,052,000 | +0.1% | 45,187 | -18.4% | 1.24% | -8.2% |
| Q1 2018 | $4,049,000 | +28.9% | 55,347 | +2.3% | 1.35% | +31.0% |
| Q4 2017 | $3,142,000 | +25.4% | 54,097 | -3.1% | 1.03% | +24.2% |
| Q3 2017 | $2,506,000 | +13.7% | 55,847 | 0.0% | 0.83% | +31.5% |
| Q2 2017 | $2,205,000 | -22.7% | 55,847 | -20.6% | 0.63% | -7.2% |
| Q1 2017 | $2,853,000 | -8.2% | 70,317 | -9.1% | 0.68% | -4.2% |
| Q4 2016 | $3,108,000 | +3.1% | 77,317 | -7.1% | 0.71% | -0.4% |
| Q3 2016 | $3,014,000 | +23.0% | 83,237 | -1.5% | 0.71% | +12.5% |
| Q2 2016 | $2,450,000 | -17.1% | 84,497 | 0.0% | 0.63% | -32.8% |
| Q1 2016 | $2,956,000 | +5.9% | 84,497 | -2.4% | 0.94% | +6.3% |
| Q4 2015 | $2,791,000 | – | 86,557 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |